Shopping Cart
- Remove All
Your shopping cart is currently empty
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 is a synthetic conjugate that combines a Thalidomide-based cereblon ligand and a linker, commonly utilized in PROTAC technology. This compound serves as a connector between the target protein and the E3 ligase, facilitating targeted protein degradation.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 100 mg | Inquiry | Backorder | |
| 500 mg | Inquiry | Backorder |
| Description | Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 is a synthetic conjugate that combines a Thalidomide-based cereblon ligand and a linker, commonly utilized in PROTAC technology. This compound serves as a connector between the target protein and the E3 ligase, facilitating targeted protein degradation. |
| In vitro | PROTACs consist of two distinct ligands linked together: one targets an E3 ubiquitin ligase, and the other binds to a target protein. They leverage the intracellular ubiquitin-proteasome system to selectively degrade target proteins [2]. |
| Synonyms | Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2, E3LigaseLigand-LinkerConjugates23, Cereblon Ligand-Linker Conjugates 12 |
| Molecular Weight | 534.566 |
| Formula | C25H34N4O9 |
| Cas No. | 2435572-48-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.